Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 17/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31488945 | 0.86 | NAMPT (0.57) | NAMPTNPC1MAPTRAB9ACYP3A4 | |
| SCHEMBL31488966 | 0.84 | NAMPT (0.51) | NAMPTNPC1MAPTRAB9A | |
| SCHEMBL31489014 | 0.83 | NAMPT (0.70) | NAMPTNPC1MAPTRAB9ACYP3A4 | |
| SCHEMBL31488795 | 0.83 | NAMPT (0.67) | NAMPT | |
| Hydrochloric Acid SCHEMBL31488963 | 0.83 | NAMPT (0.66) | NAMPT | |
| SCHEMBL31488848 | 0.82 | NAMPT (0.71) | NAMPTNPC1MAPTRAB9ACYP3A4 | |
| SCHEMBL31488821 | 0.82 | NAMPT (0.52) | NAMPTNPC1MAPTRAB9A | |
| SCHEMBL31488991 | 0.81 | NAMPT (0.52) | NAMPTNPC1MAPTRAB9ACYP3A4 | |
| SCHEMBL31488961 | 0.81 | NAMPT (0.78) | NAMPTNPC1MAPTRAB9ACYP3A4 | |
| SCHEMBL31488875 | 0.81 | NAMPT (0.57) | NAMPTNPC1MAPTRAB9ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072437-A1 | HETEROARYL COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | ALPHINA THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |